Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06019611 · ClinicalTrials.gov registry record · NA
Epidural Stimulation in Multiple Sclerosis
A NA study, sponsored by Kristin Zhao, PhD.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT06019611: Completed NA study, sponsored by Kristin Zhao, PhD.
NCT06019611 is a NA study that has completed, run by Kristin Zhao, PhD. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06019611, a NA study, has completed, sponsored by Kristin Zhao, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
A study to quantify changes in motor performance of epidural stimulation in progressive multiple sclerosis (MS) patients over the course of 12 rehabilitation sessions.
Primary Outcome
Change in maximum knee flexion, measured in degrees. Difference in maximum knee flexion between Baseline and End of Study with epidural stimulation off, and at End of Study between epidural stimulation off and epidural stimulation on.
Interventions
- DEVICE Percutaneous epidural stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2024-02-27 |
| Phase | NA |
What the finished NCT06019611 record still lists
NCT06019611 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Percutaneous epidural stimulation is the first listed.
NCT06019611 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06019611 about?
NCT06019611 is a clinical study titled "Epidural Stimulation in Multiple Sclerosis". A study to quantify changes in motor performance of epidural stimulation in progressive multiple sclerosis (MS) patients over the course of 12 rehabilitation sessions.
What is the current status of trial NCT06019611?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2023-09-11. Estimated completion is 2024-02-27.
What interventions are being tested in trial NCT06019611?
The interventions under investigation include: Percutaneous epidural stimulation (DEVICE).
Who is sponsoring clinical trial NCT06019611?
This trial is sponsored by Kristin Zhao, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06019611's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI